Randomized comparative study of amoxicillin-clavulanic acid and co-trimoxazole in the treatment of acute urinary tract infections in adults.

Abstract

The efficacy and safety of amoxicillin-clavulanic acid were compared with those of co-trimoxazole in the treatment of acute urinary tract infections. A total of 104 patients (mean age, 52 years) with clinical and laboratory evidence of acute urinary tract infection were enrolled in the study. Characteristics and infecting organisms were equivalent in both groups of patients. Escherichia coli was the predominant bacteria pathogen in both groups. Both drugs resulted in clinical improvement in 100% of the patients; bacteriological cure after the termination of therapy was 95% with amoxicillin-clavulanic acid and 83% with co-trimoxazole (P less than 0.001). Side effects were not severe enough to necessitate discontinuation of the antimicrobial agents. Amoxicillin-clavulanic acid is effective and safe therapy for acute urinary tract infections caused by susceptible bacteria.

• Authors: G N Karachalios
• Journal: Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 28 Issue 5 Pg. 693-4 (Nov 1985) ISSN: 0066-4804 [Print] United States
• PMID: 3911880 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)

Chemical References

• Anti-Infective Agents, Urinary
• Clavulanic Acids
• Drug Combinations
• Clavulanic Acid
• Amoxicillin
• Trimethoprim, Sulfamethoxazole Drug Combination
• Trimethoprim
• Sulfamethoxazole

Topics

• Acute Disease
• Adolescent
• Adult
• Aged
• Amoxicillin (therapeutic use)
• Anti-Infective Agents, Urinary (therapeutic use)
• Clavulanic Acid
• Clavulanic Acids (therapeutic use)
• Clinical Trials as Topic
• Drug Combinations (therapeutic use)
• Female
• Humans
• Male
• Middle Aged
• Random Allocation
• Sulfamethoxazole (therapeutic use)
• Trimethoprim (therapeutic use)
• Trimethoprim, Sulfamethoxazole Drug Combination
• Urinary Tract Infections (drug therapy, urine)